Methods: 50 pure archival OCCCs were reviewed by at least two gynaecologic pathologists, and subjected to microarray-based comparative genomic hybridisation (aCGH) using a 32K tiling-path platform.

TheChina Microarray Market Analysis Report 2024-2031: Use of Microarrays in Forensics and Growing Adoption of 3D-printed Microarrays Impact on the $900+ Million Industry - ResearchAndMarkets.com ...

Analysis of histological sections of disease tissues has traditionally relied on pathologist-based scoring. In an Advanced Online Publication in Nature Medicine Camp et al. describe techniques to ...

Use of molecular signatures of gastric cancers derived from microarray analysis of paraffin-embedded specimens to predict the degree of response to CPT11/S-1 chemotherapy ...

The technology represents a unique approach to microarray analysis, enabling optimal signal-to-background ratio for biotin-labeled molecules, according to Margit Stadler, Ph.D., product line manager.

Microarray-Based Prenatal Diagnosis for the Identification of Fetal Chromosome Abnormalities Lisa G Shaffer; Jill A Rosenfeld Disclosures Expert Rev Mol Diagn. 2013;13 (6):601-611.

Fingerprint analysis of serum antibodies with PEPperPRINT’s new peptide microarray platform. Don’t Cry Robert Sack, Ph.D., SUNY College of Optometry professor, uses conventional commercial ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate ...

About Vaxxas Vaxxas is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary high-density microarray patch (HD-MAP).